Inside Salk; Salk Insitute
Home > News & Press > InsideSalk > 02|11 Issue > Salk Establishes the Renato Dulbecco Chair in Genomics and the Roger Guillemin Chair in Neuroscience with $6 Million Gift from Irwin and Joan Jacobs

Salk Establishes the Renato Dulbecco Chair in Genomics and the Roger Guillemin Chair in Neuroscience with $6 Million Gift from Irwin and Joan Jacobs

Renato Dulbecco and Roger Guillemin

Nobel laureates Renato Dulbecco and Roger Guillemin

A $6 million gift from Irwin Jacobs, chairman of the Salk's Board of trustees, and his wife, Joan Klein Jacobs, will be used to create the Renato Dulbecco Chair in Genomics and the Roger Guillemin Chair in Neuroscience.

"Joan and I are particularly pleased to establish these chairs to recognize our two resident Nobel Prize winners, Drs. Dulbecco and Guillemin, for their incredible achievements in science and research, for the leadership they have provided over the years at Salk, and for the legions of scientists they continue to mentor and inspire," said Jacobs.

Renato Dulbecco, a founding fellow and president emeritus of the Salk Institute, conducted seminal research that provided the first clue to the genetic nature of cancer. He was jointly awarded the 1975 Nobel Prize in Physiology or Medicine for discoveries concerning the interaction between tumor viruses and a cell's genetic matter. In 1986, Dulbecco initiated the idea of studying all human genes, helping to launch the worldwide Human Genome Project.

Roger Guillemin, a distinguished professor and former president of the Institute, won the Nobel Prize in 1977 for discoveries that laid the foundation for brain hormone research. Considered the founder of the field of neuroendocrinology, Guillemin is a scientific pioneer whose work has led to treatments for disorders ranging from infertility to diabetes to pituitary tumors.

"The creation of each chair will pay permanent tribute to the extraordinary research contributions of these two remarkable scientists," said William Brody, Salk president. "The central roles played by Dr. Dulbecco in genomics and Dr. Guillemin in neuroscience have built a legacy of leadership and innovation that will remain embedded in the Institute now and for years to come."